RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank44
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-12.29%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -57.51% |
| Q4 2024 | 0.00% |
| Q3 2024 | 48.52% |
| Q2 2024 | 0.00% |
| Q1 2024 | 65.72% |
| Q4 2023 | 0.00% |
| Q3 2023 | 14.79% |
| Q2 2023 | -47.36% |
| Q1 2023 | -196.82% |
| Q4 2022 | 59.84% |
| Q3 2022 | 63.65% |
| Q2 2022 | -299.06% |
| Q1 2022 | 72.04% |
| Q4 2021 | 21.90% |
| Q3 2021 | -0.67% |
| Q2 2021 | -54.06% |
| Q1 2021 | 3.45% |
| Q4 2020 | -38.53% |
| Q3 2020 | 38.98% |
| Q2 2020 | -41.46% |
| Q1 2020 | 23.40% |
| Q4 2019 | -55.94% |
| Q3 2019 | 14.91% |
| Q2 2019 | -38.76% |
| Q1 2019 | 8.07% |
| Q4 2018 | 2.13% |
| Q3 2018 | 0.32% |
| Q2 2018 | 11.55% |
| Q1 2018 | 32.97% |
| Q4 2017 | -34.21% |
| Q3 2017 | -8.50% |
| Q2 2017 | 5.75% |
| Q1 2017 | -1.48% |
| Q4 2016 | -37.99% |
| Q3 2016 | -28.46% |
| Q2 2016 | -15.18% |
| Q1 2016 | 17.37% |
| Q4 2015 | -60.92% |
| Q3 2015 | 19.96% |